Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab

Author:

Yu Chuanfei1,Zhang Feng1,Xu Gangling1,Wu Gang1,Wang Wenbo1,Liu Chunyu1,Fu Zhihao1,Li Meng1,Guo Sha1,Yu Xiaojuan1,Wang Lan1ORCID

Affiliation:

1. Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, No. 29, Huatuo Road, Daxing District, Beijing 102629, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Institutes for Food and Drug Control

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Reference27 articles.

1. Avastin (bevacizumab) full prescribing information. Genentech, Inc.: South San Francisco, CA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125085s323lbl.pdf (accessed January 17, 2020).

2. Shanghai eye treatment outbreak: bevacizumab therapy for AMD in China

3. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

4. Vascular Endothelial Growth Factor: Basic Science and Clinical Progress

5. U.S. Food and Drug Administration Briefing Document. Background information for the Oncologic Drugs Advisory Committee: Biologics License Application for ABP 215. Submitted July 13, 2017, by Amgen, Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3